| BCLC | the Barcelona Clinic Liver Cancer |
| CT | computed tomography |
| HCC | hepatocellular carcinoma |
| ICI | immune checkpoint inhibitors |
| mRECIST | the modified Response Evaluation Criteria in Solid Tumors |
| NCI-CTCAE | The National Cancer Institute–Common Terminology Criteria for Adverse Events |
| ORR | overall response rate |
| OS | overall survival |
| PFS | progression-free survival |
| PVTT | portal vein tumor thrombus |
| SBRT | stereotactic body radiation therapy |
| SD | standard deviation |
| TACE | transcatheter arterial chemoembolization |
| TKI | tyrosine kinase inhibitor |